3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Multiple Myeloma
800
Precursor Cell Lymphoblastic Leukemia-Lymphoma
169
Recurrence
140
Neoplasms, Plasma Cell
110
Lymphoma
93
Leukemia
91
Neoplasms
81
Burkitt Lymphoma
57
Vomiting
51
Lymphoma, Non-Hodgkin
50
Immunoglobulin Light-chain Amyloidosis
49
Lymphoma, Large B-Cell, Diffuse
44
Nausea
38
Lymphoma, Mantle-Cell
38
Prostatic Neoplasms
31
Lymphoma, Follicular
30
Hodgkin Disease
29
Waldenstrom Macroglobulinemia
27
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
27
Neoplasm Metastasis
26
Leukemia, Lymphocytic, Chronic, B-Cell
26
Carcinoma, Non-Small-Cell Lung
26
Leukemia, Myeloid, Acute
25
Breast Neoplasms
25
Lung Neoplasms
22
Amyloidosis
21
Leukemia, Biphenotypic, Acute
18
Lymphoma, B-Cell, Marginal Zone
17
Lymphoma, Extranodal NK-T-Cell
16
Smoldering Multiple Myeloma
15
Interventions
Gemcitabine
13
pembrolizumab
9
Specimen Handling
9
enfortumab vedotin
8
Cisplatin
8
Magnetic Resonance Spectroscopy
7
avelumab
5
Carboplatin
5
vinflunine
4
Nivolumab
4
atezolizumab
3
Immunoglobulin G
3
Disulfides
3
Biopsy
3
eribulin
2
cabozantinib
2
Standard of Care
2
Ramucirumab
2
Radiotherapy
2
Platinum
2
Nephroureterectomy
2
Ipilimumab
2
Doxorubicin
2
Docetaxel
2
CTLA-4 Antigen
2
Bortezomib
2
1,2-diaminocyclohexaneplatinum II citrate
2
vandetanib
1
tremelimumab
1
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Ureteral Neoplasms
×
Dexamethasone
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled